Evidence map›Paper›PMID 23229615›Full record

ArticleMycopathologia2013

In vitro susceptibility of environmental isolates of Exophiala dermatitidis to five antifungal drugs.

Ana Paula Miranda Duarte, Fernando Carlos Pagnocca, Noemi Carla Baron, Marcia de Souza Carvalho Melhem, Gislene Aparecida Palmeira, Dejanira de Franceschi de Angelis, Derlene Attili-Angelis

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Virulence · 2019
    Review
  3. Article
  4. A case ofJMM case reports · 2017
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana Paula Miranda DuarteCenter for Study of Social Insects, IB, UNESP- São Paulo State University, Rio Claro, SP, Brazil.
Fernando Carlos Pagnocca
Noemi Carla Baron
Marcia de Souza Carvalho Melhem
Gislene Aparecida Palmeira
Dejanira de Franceschi de Angelis
Derlene Attili-Angelis

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several dematiaceous fungi frequently isolated from nature are involved in cases of superficial lesions to lethal cerebral infections. Antifungal susceptibility data on environmental and clinical isolates are still sparse despite the advances in testing methods. The objective of this study was to examine the activities of 5-flucytosine, amphotericin B, itraconazole, voriconazole and terbinafine against environmental isolates of Exophiala strains by minimum inhibition concentration (MIC) determination. The strains were obtained from hydrocarbon-contaminated soil, ant cuticle and fungal pellets from the infrabuccal pocket of attine gynes. Broth microdilution assay using M38-A2 reference methodology for the five antifungal drugs and DNA sequencing for fungal identification were applied. Terbinafine was the most active drug against the tested strains. It was observed that amphotericin B was less effective, notably against Exophiala spinifera, also studied. High MICs of 5-flucytosine against Exophiala dermatitidis occurred. This finding highlights the relevance of studies on the antifungal resistance of these potential opportunistic species. Our results also contribute to a future improvement of the standard methods to access the drug efficacy currently applied to black fungi.

Indexed as

Environmental MicrobiologyAntifungal AgentsDNA, FungalDNA, Ribosomal SpacerExophialaHumansMicrobial Sensitivity TestsSequence Analysis, DNAAntifungal AgentsDNA, FungalDNA, Ribosomal Spacer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.